Therapeutic trials and clinical pharmacologic studies of the new terephthalanilide derivative, 2-amino-4,'4"-bis(4-methyl-2-imidazolin-2-yl)-terephthalanilide (AMIT) (NSC 66761).
D000328:Adult; D000368:Aged; D000813:Anilides / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use* / Q000652:urine; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002675:Child, Preschool; D006801:Humans; D007275:Injections, Intravenous; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*
D000813:Anilides; D000970:Antineoplastic Agents